Lung transplant outcomes for recipients with alpha-1 antitrypsin deficiency, by use of alpha-1 antitrypsin augmentation therapy

Background: For patients with alpha-1 antitrypsin (AAT) deficiency, AAT augmentation therapy can be an important part of care. However, for those who require a lung transplant (LT), there is currently only limited information to guide the use of AAT augmentation therapy post-LT. Methods: We identifi...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Atharv V. Oak, MEng, Jessica M. Ruck, MD, PhD, Alfred J. Casillan, MD, PhD, Armaan F. Akbar, BS, Ramon A. Riojas, MD, PhD, Pali D. Shah, MD, Jinny S. Ha, MD, MHS, Sara Strout, PharmD, Allan B. Massie, PhD, Dorry L. Segev, MD, PhD, Christian A. Merlo, MD, MPH, Errol L. Bush, MD
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2025-02-01
Saila:	JHLT Open
Gaiak:	alpha-1 antitrypsin emphysema lung transplant augmentation therapy survival outcomes
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2950133424001514
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!